EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy

Alexander Rühle, Sebastian Marschner, Marlen Haderlein, Alexander Fabian, Maria Weymann, Max Behrens, Carolin Senger, Daniel R Dickstein, Johannes Kraft, Jens von der Grün, Eric Chen, Todd Aquino-Michaels und 22 weitere

JAMA Network Open · 20.02.2023 · 6 (2) · e230090

DOI: 10.1001/jamanetworkopen.2023.0090 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JAMA Network Open, online erschienen am 20.02.2023. Verfasst von Alexander Rühle und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Freiburg-Medical Center, Freiburg, Germany. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Head and Neck Neoplasms. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance The number of older adults with head and neck squamous cell carcinoma (HNSCC) is increasing, and these patients are underrepresented in clinical trials. It is unclear whether the addition of chemotherapy or cetuximab to radiotherapy is associated with improved survival in older adults with HNSCC.

Objective

To examine whether the addition of chemotherapy or cetuximab to definitive radiotherapy is associated with improved survival in patients with locoregionally advanced (LA) HNSCC. Design, Setting, and Participants The Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy (SENIOR) study is an international, multicenter cohort study including older adults (≥65 years) with LA-HNSCCs of the oral cavity, oropharynx/hypopharynx, or larynx treated with definitive radiotherapy, either alone or with concomitant systemic treatment, between January 2005 and December 2019 at 12 academic centers in the US and Europe. Data analysis was conducted from June 4 to August 10, 2022.

Interventions

All patients underwent definitive radiotherapy alone or with concomitant systemic treatment. Main Outcomes and Measures The primary outcome was overall survival. Secondary outcomes included progression-free survival and locoregional failure rate.

Results

Among the 1044 patients (734 men [70.3%]; median [IQR] age, 73 [69-78] years) included in this study, 234 patients (22.4%) were treated with radiotherapy alone and 810 patients (77.6%) received concomitant systemic treatment with chemotherapy (677 [64.8%]) or cetuximab (133 [12.7%]). Using inverse probability weighting to attribute for selection bias, chemoradiation was associated with longer overall survival than radiotherapy alone (hazard ratio [HR], 0.61; 95% CI, 0.48-0.77; P < .001), whereas cetuximab-based bioradiotherapy was not (HR, 0.94; 95% CI, 0.70-1.27; P = .70). Progression-free survival was also longer after the addition of chemotherapy (HR, 0.65; 95% CI, 0.52-0.81; P < .001), while the locoregional failure rate was not significantly different (subhazard ratio, 0.62; 95% CI, 0.30-1.26; P = .19). The survival benefit of the chemoradiation group was present in patients up to age 80 years (65-69 years: HR, 0.52; 95% CI, 0.33-0.82; 70-79 years: HR, 0.60; 95% CI, 0.43-0.85), but was absent in patients aged 80 years or older (HR, 0.89; 95% CI, 0.56-1.41). Conclusions and Relevance In this cohort study of older adults with LA- HNSCC, chemoradiation, but not cetuximab-based bioradiotherapy, was associated with longer survival compared with radiotherapy alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellHead and Neck NeoplasmsMaleAgedHumansSquamous Cell Carcinoma of Head and NeckCohort StudiesCetuximab

Substanzen

Cetuximab

Autor:innen und Institutionen

  • Department of Radiation Oncology, University of Freiburg-Medical Center, Freiburg, Germany.
  • German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
  • DKTK Partner Site Munich, German Cancer Research Center, Heidelberg, Germany.
  • Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Comprehensive Cancer Center Erlangen-EMN, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

Zitieren

APA

Rühle, A., Marschner, S., Haderlein, M., Fabian, A., Weymann, M., Behrens, M., Senger, C., Dickstein, D. R., Kraft, J., von der Grün, J., Chen, E., Aquino-Michaels, T., Domschikowski, J., Bickel, A., Altay-Langguth, A., Kalinauskaite, G., Lewitzki, V., Ferentinos, K., Zamboglou, C., …, & Nicolay, N. H. (2023). Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy. JAMA Network Open, 6(2), e230090. https://doi.org/10.1001/jamanetworkopen.2023.0090

Vancouver

Rühle A, Marschner S, Haderlein M, Fabian A, Weymann M, Behrens M, et al. Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy. JAMA Network Open. 2023;6(2):e230090. doi:10.1001/jamanetworkopen.2023.0090

BibTeX
@article{Rhle2023,
  author = {Rühle, Alexander and Marschner, Sebastian and Haderlein, Marlen and Fabian, Alexander and Weymann, Maria and Behrens, Max and Senger, Carolin and Dickstein, Daniel R and Kraft, Johannes and von der Grün, Jens and Chen, Eric and Aquino-Michaels, Todd and Domschikowski, Justus and Bickel, Amanda and Altay-Langguth, Alev and Kalinauskaite, Goda and Lewitzki, Victor and Ferentinos, Konstantinos and Zamboglou, Constantinos and Schnellhardt, Sören and Haehl, Erik and Spohn, Simon K B and Gkika, Eleni and Zöller, Daniela and Guckenberger, Matthias and Budach, Volker and Belka, Claus and Bakst, Richard and Mayer, Arnulf and Schmidberger, Heinz and Grosu, Anca-Ligia and Balermpas, Panagiotis and Stromberger, Carmen and Nicolay, Nils H},
  title = {Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy},
  journal = {JAMA Network Open},
  year = {2023},
  volume = {6},
  number = {2},
  pages = {e230090},
  doi = {10.1001/jamanetworkopen.2023.0090}
}
Kostenlos starten →